This presentation provides the laboratory and operational requirements of immuno-oncology trials, and explores trends in I-O drug development and biomarker usage. Q² Solutions presented at the Immuno-Oncology 360° 2019 conference as part of a plenary session.

Q² Solutions has a unique role in immuno-oncology drug development, providing clinical laboratory services and utilizing early engagement and continuous communication with partners and clients to drive higher quality results.

Download this presentation to learn more.

Speaker:
Patrice Hugo, PhD, Chief Scientific Officer